Response by Latif et al to Letter Regarding Article, "Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial"
Faisal Latif, Emmanouil S. Brilakis(Minneapolis Heart Institute Foundation), Raghava S. Velagaleti(VA Boston Healthcare System), Deepak L. Bhatt(Mount Sinai Hospital), Subhash Banerjee(Baylor University Medical Center), Edwards McFalls(University of Minnesota), Sunil V. Rao(New York University), Bavana V. Rangan(Minneapolis Heart Institute Foundation), Mei-Chiung Shih(The Coordinating Center), Steven Goldman(University of Arizona), Scott Kinlay, Vasilios Papademetriou(Hippocration General Hospital), Robert Edson(Program Support Center), Kendrick Shunk(San Francisco VA Medical Center), Lauren Uyeda(Program Support Center), Kul Aggarwal(University of Missouri Health System), Kreton Mavromatis, Islam Bolad(Richard L. Roudebush VA Medical Center), Barry F. Uretsky(Central Arkansas Veterans Healthcare System), David R. Holmes(Mayo Clinic in Florida), Huu Tam Truong, Anand Irimpen(Tulane University), Khaled M. Ziada(Cleveland Clinic)
Cited by 0
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
Mayo Clinic Proceedings
|Mayo Clinic Proceedings|2000|2.2k